Exagen Inc. XGN Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$19.95M-32.0% | -$15.12M+36.2% | -$23.69M+50.0% | -$47.39M-76.5% | ||
| $2.16M+22.4% | $1.76M-51.3% | $3.62M-23.1% | $4.7M-0.5% | ||
| $378K+145% | $154K-1.3% | $156K-3.1% | $161K-42.3% | ||
| —— | —— | —— | -$3.58M-581% | ||
| $42K-86.4% | $308K+360% | $67K— | —— | ||
| $251K— | —— | $2.58M— | —— | ||
| -$792K— | —— | —— | —— | ||
| -$147K— | —— | —— | —— | ||
| —— | $733K— | —— | —— | ||
| -$1.1M-12.3% | -$976K+3.4% | -$1.01M-18.3% | -$854K— | ||
| —— | -$13.64M— | —— | -$32.14M-58.6% | ||
| $641K+24.5% | $515K-37.8% | $828K-80.8% | $4.32M+82.2% | ||
| —— | $0— | —— | —— | ||
| -$626K-21.6% | -$515K+35.9% | -$804K+81.4% | -$4.32M-78.4% | ||
| $592K— | $0— | —— | $0— | ||
| —— | $0— | —— | $0— | ||
| $494K+0.8% | $490K-29.7% | $697K+4.5% | $667K+27.0% | ||
| $869K— | $0— | —— | —— | ||
| $24.82M+3,843% | -$663K+93.8% | -$10.63M-2,074% | -$489K— | ||
| —— | -$14.46M— | —— | -$36.95M— | ||
| $2.99M+73.8% | $1.72M-1.0% | $1.74M+0.3% | $1.73M-4.6% | ||
| $378K+145% | $154K-1.3% | $156K-3.1% | $161K-42.3% | ||
| $777K— | —— | —— | —— | ||
| $2.12M+22.9% | $1.72M-20.5% | $2.17M+39.2% | $1.56M+64.2% | ||
| $251K— | —— | $2.58M— | —— | ||
| -$1.1M-12.3% | -$976K+3.4% | -$1.01M-18.3% | -$854K— | ||
| —— | $1.79M+173% | $654K+29.5% | $505K— | ||
| —— | —— | —— | —— | ||
| -$147K— | —— | —— | —— | ||
| —— | $0— | —— | —— | ||
| $494K+0.8% | $490K-29.7% | $697K+4.5% | $667K+27.0% | ||
| $869K— | —— | —— | —— | ||
| $398K— | —— | —— | —— | ||
| $592K+59.6% | $371K+53.9% | $241K+731% | $29K— | ||
| $25K-96.6% | $736K— | —— | —— | ||
| $3.28M— | $0— | —— | —— | ||
| —— | $0— | —— | —— | ||
| —— | $733K— | —— | —— | ||
| -$1.1M-12.3% | -$976K+3.4% | -$1.01M-18.3% | -$854K— | ||
| $3.23M— | $0— | —— | $741K-33.3% | ||
| —— | -$14.01M— | —— | -$36.46M-61.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Exagen Inc. generate?
- Exagen Inc. (XGN) generated -$27.0M in operating cash flow over the trailing twelve months.
- What is Exagen Inc.'s free cash flow?
- After $756.0K of capital expenditures, Exagen Inc.'s free cash flow was -$27.6M over the trailing twelve months, down 96.9% year over year.
- Where does Exagen Inc.'s cash flow data come from?
- Every line is extracted from Exagen Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
